Journal
EMBO JOURNAL
Volume 28, Issue 2, Pages 88-98Publisher
WILEY
DOI: 10.1038/emboj.2008.266
Keywords
HER2; L45; migration; Smad; TGF beta
Categories
Funding
- Howard Hughes Medical Institute Funding Source: Medline
- NIEHS NIH HHS [T32 ES007031, T32ES07031] Funding Source: Medline
- NIGMS NIH HHS [T32 GM007105, R01 GM083000, 1R01GM083000-01, 5T32GM007105] Funding Source: Medline
Ask authors/readers for more resources
During the course of breast cancer progression, normally dormant tumour-promoting effects of transforming growth factor beta (TGF beta), including migration, invasion, and metastasis are unmasked. In an effort to identify mechanisms that regulate the pro-migratory TGF beta 'switch' in mammary epithelial cells in vitro, we found that TGF beta stimulates the phosphorylation of Smad1 and Smad5, which are typically associated with bone morphogenetic protein signalling. Mechanistically, this phosphorylation event requires the kinase activity and, unexpectedly, the L45 loop motif of the type I TGF beta receptor, ALK5, as evidenced by studies using short hairpin RNA-resistant ALK5 mutants in ALK5-depleted cells and in vitro kinase assays. Functionally, Smad1/5 co-depletion studies demonstrate that this phosphorylation event is essential to the initiation and promotion of TGF beta-stimulated migration. Moreover, this phosphorylation event is preferentially detected in permissive environments such as those created by tumorigenic cells or oncogene activation. Taken together, our data provide evidence that TGF beta-stimulated Smad1/5 phosphorylation, which occurs through a non-canonical mechanism that challenges the notion of selective Smad phosphorylation by ALK5, mediates the pro-migratory TGF beta switch in mammary epithelial cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available